ARTICLE | Clinical News
MSC_Apceth: Phase I/II started
September 5, 2011 7:00 AM UTC
Apceth began an open-label, German Phase I/II trial to compare percutaneous transluminal angioplasty followed by infusion of MSC_Apceth vs. percutaneous transluminal angioplasty alone in 30 patients. ...